What’s Causing Tharimmune Stock (THAR) to Surge?
Tharimmune, Inc. (THAR) saw its shares surge by 207% on Wednesday following the announcement of encouraging simulation results for its primary clinical candidate, TH104. After hours, the stock climbed an additional 42%. Investment Strategy Insights Consider exploring investment tools that provide access to expert analysis and data. What is Tharimmune? Tharimmune is a biotechnology firm […]